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Supplementary Methods 
 
Construction of expression plasmids and viruses 
All constructs were generated using standard molecular biology methods and verified by 
DNA sequencing.  
pLEMPRA CREB.  Rat CREB cDNA, containing an N-terminal Flag tag, was cloned into 
the lentiviral expression vector pLEMPRA-GOI (provided by M. Greenberg) 
immediately following the GFP-IRES sequence.  Subsequently a CREB shRNA cassette 
(described below) was subcloned into the pLEMPRA vector.  The CREB sequence was 
made shRNA-resistant by introducing the following five silent mutations (lower case 
letters): GGAGagcGTGGATAGcGTg.  Various CREB alanine mutations were created 
from the resulting vector using the QuikChange Lightning Mutagenesis kit (Stratagene).  
 pLenti CREB.  The pLenti WT and alanine mutant CREB plasmids were created by 
subcloning Flag-tagged WT and alanine mutant CREB sequences from the pLEMPRA 
CREB vectors in place of the H2B sequence in the lentiviral expression plasmid pLenti 
PGK:H2B:mCherry (provided by R. Lansford).  A T2A sequence was inserted between 
the CREB and mCherry sequences.  
shRNA.  shRNA sequences targeting mouse CREB (5’-GGAGTCTGTGGATAGTGTA-
3’)1, mouse CRTC2 (5’-GATGCTAAAGTCCCTGCTATT-3’) or no mouse transcript 
(5’-CAACAAGATGAAGAGCACC-3’; scramble) were inserted into the lentiviral 
expression vector pLLX-shRNA2.    
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HSV CREB.  The S40A HSV CREB plasmid was constructed by cloning S40A rat CREB 
cDNA in place of WT CREB into the bicistronic HSV amplicon p1005+:CREB 
(provided by S. Josselyn), in which CREB and eGFP expression are driven by IE4/5 and 
T7 promoters, respectively.  The amplicons were packaged as previously described3. 
pA2UCOE-OGT.  Rat OGT cDNA was first cloned into the pLEMPRA-GOI vector 
immediately following the GFP-IRES-Flag sequence.  Subsequently the entire GFP-
IRES-Flag-OGT sequence was subcloned in place of the EGFP sequence in the lentiviral 
expression vector pA2UCOE-EGFP4. 
 
Cell cultures and transfection   
Neuro2a cells were maintained in DMEM supplemented with 10% fetal bovine serum 
(FBS) and penicillin/streptomycin (100 U ml-1).  Transfections were performed using 
Lipofectamine LTX and PLUS reagents according to the manufacturer’s protocol 
(Invitrogen). 
Cortical neuronal cultures were prepared as previously described5, except that neurons 
from E15-16 timed-pregnant C57BL/6 mice were plated onto poly-DL-lysine coated 
plates or coverslips.  For pharmacological treatment and ChIP experiments, neurons were 
cultured in Neurobasal medium (NBM) supplemented with 2 mM Glutamax-I, 
penicillin/streptomycin (100 U ml-1), and 2% B-27 (Invitrogen).  For reverse transcription 
PCR (RT-PCR) and neurite outgrowth experiments, neurons were cultured in NBM 
supplemented with 10% FBS and 2 mM Glutamax-I.  Neurons were electroporated with 
vectors and siRNA using the program K-09 on the Nucleofector Device (Lonza) 
according to the manufacturer’s instructions. 
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Identification of O-GlcNAc glycosylation sites on CREB 
Neuro2a cells transfected with WT pLEMPRA CREB were treated with O-(2-acetamido-
2-deoxy-D-glucopyranosylidene)amino N-phenylcarbamate (PUGNAc, 100 µM, 6 h; 
Toronto Research Chemicals) to inhibit β-N-acetylglucosaminidase and lysed in 1.5% 
SDS containing Complete™ protease inhibitor cocktail (Roche) and 5 µM PUGNAc.  The 
lysate (7.5 mg) was diluted 1.5-fold, quenched with one volume of NETFS buffer (100 
mM NaCl, 50 mM Tris-HCl pH 7.4, 5 mM EDTA, PIC, 5 µM PUGNAc) containing 6% 
(v/v) NP-40 and then was further diluted to 2 mg ml-1 with NETFS buffer.  The sample 
was passed over 400 µl of anti-Flag M2 affinity gel three times, washed three times with 
10 ml of NETFS containing 1% (v/v) NP-40, washed twice with 10 ml of NETFS, eluted 
in 400 µl of 4% SDS, 100 mM Tris pH 7.9, and concentrated to a volume of 20 µl.  After 
SDS-PAGE (4-12% Bis-Tris gels), the CREB band was excised and manually digested 
in-gel with chymotrypsin as previously described6.  Nano LC-MS of peptides was 
performed as previously described using a 60-min linear gradient on an LTQ XL 
(Thermo Fisher)7.  MS/MS spectra were collected in both CID and ETD modes using 
separate analyses.  MS /MS were searched using Mascot 2.2 against a custom database 
containing Flag-CREB and 200 other proteins.  ETD spectra were first converted to 
*.DTA files using RawXtract (Version 1.9.1) and allowing charge states up to +5 prior to 
conversion to the MGF file format using Bioworks (Version 3.3.1).  Searches were 
performed with an enzyme specificity of chymotrypsin at one terminus only, fixed 
modification of carbamidomethyl (C), and variable modifications of oxidation (M) and 
GlcNAc (S,T).  The search results were evaluated by applying a Mascot Ion Cutoff score 
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of 20 and then manually evaluating each putative GlcNAc modified peptide.  Raw CID 
data was further evaluated for the prominent neutral loss of GlcNAc using SALSA7.   
 
Site-specific analysis of CREB O-GlcNAc glycosylation stoichiometry 
To determine the O-GlcNAc stoichiometry at specific sites, WT or alanine mutant pLenti 
CREB constructs were electroporated into neurons.  After 3 DIV, neurons were 
depolarized with KCl where indicated, washed twice with ice-cold PBS, and lysed in ice-
cold lysis buffer (10 mM HEPES, 10 mM KCl, 2 mM MgCl2, 0.5% NP-40, 0.2 mM 
Na3VO4, 0.5 mM NaF, 50 mM GlcNAc, 100 µM PUGNAc, Complete™ protease 
inhibitor cocktail, and 1 mM PMSF).  Lysates were centrifuged at 4,000 xg for 5 min at 4 
°C, and the supernatant was discarded.  The crude nuclear pellets were then lysed with an 
equal volume of 2% SDS with protease inhibitors, sonicated, boiled for 5 min, and 
centrifuged at 21,885 xg for 10 min.  Protein lysates (100 µg) were subsequently 
chemoenzymatically labeled with a PEG mass tag as described5.    The labeled lysates 
were subjected to 4-12% SDS-PAGE and immunoblotted.  An anti-Flag (Sigma) 
antibody was used to quantify the percentage of glycosylation on the exogenously 
expressed CREB mutants as described in Methods.  The contribution of each 
glycosylation site was determined from the decrease in glycosylation stoichiometry for 
each mutant as compared to exogenously expressed WT CREB, which was labeled in 
parallel. 
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Site-specific interplay between CREB glycosylation and phosphorylation 
To evaluate the effect of Ser40 glycosylation on Ser133 phosphorylation, WT or A5 
(mutated at all glycosylation sites except S40) pLenti CREB constructs were 
electroporated into neurons.  After 3 DIV, neurons were depolarized with KCl where 
indicated and lysed in boiling 2% SDS containing Complete™ protease inhibitor cocktail.  
The lysates (100 µg) were then chemoenzymatically labeled and immunoprecipitated for 
CREB using anti-Flag M2 affinity gel (Sigma).  Immunoprecipitated CREB was eluted 
using a Flag peptide according to the manufacturer’s protocol, resolved by SDS-PAGE, 
and immunoblotted for pS133 or CREB.  The level of Ser133 CREB was measured 
relative to the total CREB level in each sample. 
 
Luciferase reporter assays 
Neuro2a cells were transfected with WT or S40A pLEMPRA CREB, pCRE-Luc 
(Stratagene), pRL-TK (Promega), pDEST-HA-OGA (provided by L. Wells), and CREB 
shRNA vectors as indicated.  The cells were cultured for 72 h, and luciferase activities 
were measured with the Dual-Glo Luciferase Assay System (Promega) on a Victor 3 
plate reader (Perkin Elmer).  pRL-TK containing Renilla luciferase was used to 
normalize for transfection efficiency.  Lysates from neuro2a cells transfected with CREB 
or scramble shRNA, and WT or S40A pLEMPRA CREB were immunoblotted for CREB 
to confirm endogenous CREB knockdown and equal levels of WT and S40A CREB 
expression. 
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Electrophoretic mobility shift assay (EMSA)  
Neuro2a cells were transfected with WT or S40A pLEMPRA CREB and CREB shRNA 
vectors or the pMaxGFP (Lonza) control vector alone.  The nuclear fractions were 
isolated8, and the DNA-binding reaction was performed for 30 min at room temperature 
in the dark.  The 20-µl reaction consisted of protein (5 µg), 10 mM Tris pH 7.5, 150 mM 
KCl, 10 mM DTT, 0.25 mM EDTA, Poly(dIdC) (2 µg; Pierce), 20 µM PUGNAc, 2% 
glycerol, and IRDye 700-labeled EMSA oligos containing a CRE sequence (1 µl; Li-
COR).  The samples were resolved on a 10% polyacrylamide gel, and bands were 
quantified using an Odyssey Infrared Imaging System. 
 
Quantitative RT-PCR (qPCR)   
For neuro2a gene expression experiments, the cells were transfected with WT or S40A 
pLEMPRA CREB, CREB shRNA, and scramble or CRTC2 shRNA.  For neuronal gene 
expression experiments, cortical neurons were electroporated with WT or S40A 
pLEMPRA CREB and scramble (UUCUCCGAACGUGUCACGUdTdT) or CRTC1 
(CGAACAAUCCGCGGAAAUUdTdT) siRNA9.  To measure the contribution of CREB 
to the expression of each gene, neurons were electroporated with scramble or CREB 
siRNA (UACACUAUCCACAGACUCCdTdT)1.  After 3-4 days, neurons were 
pretreated overnight with TTX and depolarized with KCl for 6 h (where indicated), and 
the mRNA was extracted and purified using an RNeasy kit (Qiagen) and reverse-
transcribed with SuperScript III and random primers (Invitrogen) according to the 
manufacturer’s protocol.  Quantitative PCR was performed with FastStart Universal 
SYBR Green Master (Rox; Roche) using an ABI 7300 real-time instrument, version 1.2.  
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Relative quantities of mRNA were normalized to the ribosomal protein L3 (RPL3) 
mRNA content and were plotted relative to cells transfected with WT CREB and 
scramble siRNA.  To measure the contribution of CREB to the expression of each gene, 
CREB was knocked down by electroporating neurons with CREB siRNA.  For 
comparison, neurons were also electroporated with scramble siRNA.  The fold-change 
due to CREB alone (Supplementary Fig. 12) was calculated by subtracting the mRNA 
transcript levels of each gene in neurons electroporated with CREB siRNA (normalized 
to scramble siRNA mRNA transcript levels) from the transcript levels of each gene in 
neurons overexpressing WT or S40A CREB (normalized to WT CREB mRNA transcript 
levels).  These values were then normalized to WT CREB levels for each gene.  PCR 
primers are described in Supplementary Table 1. 
 
Co-immunoprecipitation of the CREB-CRTC complex   
Neuro2a cells were transfected with WT or S40A pLEMPRA CREB and CREB shRNA 
vectors.  After 72 h, the cells were lysed in 25 mM Tris pH 7.8, 1 mM EDTA, 150 mM 
NaCl, 0.5% NP-40, 5 µM PUGNAc, and Complete™ protease inhibitor cocktail.  After 
pre-clearing the lysate with protein A sepharose beads (GE Healthcare), the lysates were 
immunoprecipitated with anti-Flag M2 affinity gel or an anti-CRTC2 antibody 
(Calbiochem).  The co-immunoprecipitated complexes were resolved by 4-12% SDS-
PAGE and immunoblotted for Flag-CREB and CRTC2. For the Flag IP control, 
nontransfected samples were immunoprecipitated with anti-Flag M2 affinity gel.  For the 
CRTC2 IP control, transfected samples were immunoprecipitated with a rabbit IgG 
antibody (Santa Cruz).   
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Quantification of CRTC protein knockdown 
Neuro2a cells were transfected with CRTC2 shRNA or cortical neurons were 
electroporated with CRTC1 siRNA.  After 3 days (for neuro2a cells) or 4 days (for 
cortical neurons), the cells were lysed in 1% SDS containing Complete™ protease 
inhibitor cocktail.  The lysate (30 µg) was resolved by 4-12% SDS-PAGE and 
immunoblotted for CREB, CRTC1, or CRTC2. 
 
Chromatin Immunoprecipitation (ChIP) 
For experiments with exogenously expressed CREB mutants (Fig. 3e), WT or S40A 
pLenti CREB constructs were electroporated into neurons.  ChIP was performed as 
previously described10, except that the neurons were fixed for 20 min, the samples were 
treated with proteinase K (10 mg ml-1) for 2 h at 37 °C after elution, and the DNA was 
isolated by phenol/chloroform extraction followed by ethanol precipitation.  Samples 
were immunoprecipitated using protein A sepharose beads and anti-OGT (provided by G. 
Hart), anti-CREB (Upstate), anti-Flag M2, and anti-rabbit IgG (Santa Cruz) antibodies.  
In the case of the Flag IP, a control IP of nontransfected lysate with anti-Flag antibody 
was performed. Purified DNA samples were subjected to PCR for 36 cycles. PCR 
primers are described in Supplementary Table 2.  
 
Quantification of CREB glycosylation levels after auditory fear conditioning   
Male C57BL/6 mice (9-10 week old; Charles River) were placed into a conditioning 
chamber.  After 2 min, a tone (85 dB, 2000 Hz) was played for 30 s and co-terminated 
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with a footshock (2 s, 0.75 m).  After an additional 2 min, the above sequence was 
repeated.  Control mice were subjected to the above sequence without the shock.  Mice 
were placed back in their transport cage for 15 min, after which they were quickly 
euthanized with an overdose of isofluorane and decapitated.  Brains were removed, the 
amygdala dissected on ice, and the samples processed for chemoenzymatic labeling as 
described above.  
 
Auditory fear conditioning 
Surgery: 9-10 week old male C57BL/6 mice were anesthetized with isofluorane and 
placed in a stereotaxis frame.  Holes were drilled in the skull above the lateral amygdala 
[AP = -1.3, ML = +/-3.3, V = -4.8 from bregma according to previous methods3].  
Bilateral injections of WT, S40A, or control (p1005+ vector without CREB) HSV (1.5 
µl; replicative- and anterograde-defective) were delivered through a Hamilton syringe 
over 25 min.  The syringe was left in place for an additional 10 min prior to retraction.  
Mice were trained 3 days after the injections. 
Training: Mice were placed into a conditioning chamber and, after 2 min, a tone (85 dB, 
2000 Hz) was played for 30 s and co-terminating with a footshock (2 s, 0.75 mA).  This 
protocol was chosen because it afforded robust yet non-ceiling levels of freezing.  
Immediately following or 2 h after training, mice were administered 150 mg kg-1 
intraperitoneal anisomycin (Sigma) or saline where indicated. 
Conditioning: After 30 min, 2 h, or 24 h, mice were placed into a new cage.  After 3 min, 
a tone (85 dB, 2000 Hz) was played continuously for 3 min.  The mice were recorded and 
monitored for freezing (defined as no movement except breathing) every 5 s during the 
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first 3 min (pre-tone freezing) and the last 3 min (post-tone freezing) by two independent 
observers, one of whom was blind to the experimental conditions.  The percentage 
freezing was calculated as the mean from both observers divided by the total number of 
observations.  No significant differences were measured in pre-tone freezing scores 
across all experiments.  Following conditioning, mice were perfused with 4% 
paraformaldehyde.  The brains were embedded in 2% agarose, cut into 50 µm sections 
with a vibratome (Leica VT1000s), and imaged for GFP to confirm the correct injection 
site.   
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Supplementary Figure 1.  CREB is O-GlcNAc glycosylated at Ser40 and Thr227
or Thr228.  Flag-tagged CREB was isolated from transfected neuro2a cells, digested
with chymotrypsin, and subjected to electron transfer dissociation mass spectrometry
(ETD-MS).  ETD-MS was performed on the m/z 651.9 ion (a) and the m/z 781.3 ion
(b).  Shown are annotated spectra for two peptides identified to contain the O-GlcNAc
modification.  The c and z fragment ions observed were used to map the glycosylation
sites to the residues indicated in red. The methionine in the top spectrum is oxidized.
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Supplementary Figure 2.  NMDA treatment induces CREB glycosylation. Cortical
neurons (14 DIV) were stimulated with NMDA (25 µM) for 5 or 10 min and then lysed.
Lysates were chemoenzymatically labeled with a polyethylene glycol mass tag,
resolved by SDS-PAGE, and immunoblotted for CREB. (n = 3, *P < 0.01).  The
resulting glycosylation levels were normalized with respect to the glycosylation level
prior to NMDA application.  Error bars, means, and s.e.m.
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Supplementary Figure 3.  The protein synthesis inhibitor cycloheximide does not
block depolarization-induced glycosylation of CREB. Cortical neurons (5 DIV) were
silenced overnight with TTX (1 µM), pretreated with cycloheximide (Cyclo) or DMSO
vehicle (Veh) for 30 min, and then incubated in the presence or absence of KCl (55 mM) for
2 h. Lysates were chemoenzymatically labeled with a polyethylene glycol mass tag,
resolved by SDS-PAGE, and immunoblotted for CREB.  Relative glycosylation levels were
normalized to the percentage of glycosylation for endogenous CREB in untreated neurons
and averaged across multiple independent sample sets.  (n = 3, *P < 0.01).  Error bars,
means, and s.e.m.
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Supplementary Figure 4.  Forskolin induces CREB phosphorylation (a) but not
CREB glycosylation (b) in cortical neurons.  Neurons were treated after 5 DIV with
forskolin (Fsk; 10 µM) or DMSO vehicle for 2 h.  Lysates were either immunoblotted for
pSer133 CREB or chemoenzymatically labeled with a polyethylene glycol mass tag and
immunoblotted for CREB to visualize the glycosylated CREB subpopulation.  Relative
phosphorylation levels were normalized to total CREB levels.  Relative glycosylation
levels were normalized to the percentage of glycosylation for endogenous CREB in
untreated neurons and averaged across multiple independent sample sets.  (n = 3, *P <
0.01; NS, not significant). Error bars, means, and s.e.m.
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Supplementary Figure 5.  Knockdown of endogenous CREB and overexpression of
shRNA-resistant, Flag-tagged WT or S40A CREB in neuro2a cells.  (a) pLEMPRA-
CREB construct used to knockdown endogenous CREB and express Flag-tagged CREB.
(b) Knockdown of endogenous CREB using a vector containing the shRNA sequence.  (c)
Overexpression of shRNA-resistant CREB from the pLEMPRA construct. Western blots
are representative of five independent experiments.
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Supplementary Figure 6.  S40A CREB expression enhances the expression of
endogenous CREB target genes in neuro2a cells.  Neuro2a cells were transfected
with WT or S40A CREB and scramble or CRTC2 shRNA as indicated.  After 48-72 h,
mRNA was harvested, and quantitative polymerase chain reaction (qPCR) analysis of
CDKN1A, NR4A2, and OPA3 expression was performed.  RPL3 was used as an internal
control.  Fold-change is plotted relative to cells transfected with WT CREB and scramble
shRNA. (n = 8, *P < 0.01). Error bars, means, and s.e.m.
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Supplementary Figure 7. OGA overexpression mimics the effect of the S40A
mutant on CREB activity.  Neuro2a cells were transfected with WT or S40A CREB
and OGA expression plasmids as indicated, and CRE-luciferase activity was measured.
Luciferase activity was normalized with respect to WT CREB in absence of OGA
overexpression. (n = 4, * P < 0.02; NS, not significant). Error bars, means, and s.e.m.
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Supplementary Figure 8.  WT and S40A CREB show similar binding to the
CRE promoter in vitro.  Neuro2a cells were transfected with WT or S40A CREB,
lysed, and an electrophoretic mobility shift assay was performed using IRDye 700-
labeled oligos containing a CRE promoter sequence. (n = 3; NS, not significant).
Error bars, means, and s.e.m.
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Supplementary Figure 9. Reciprocal co-immunoprecipitations of the CREB-
CRTC2 complex.   Neuro2a cells expressing WT or S40A CREB were lysed and
immunoprecipitated for Flag-CREB (a) or CRTC2 (b).  The co-immunoprecipitated
proteins were immunoblotted with the indicated antibodies.  Control blots showed
equal amounts of protein input of CRTC2 (a) or CREB (b) and pulldown of CREB
(a) or CRTC (b).
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Supplementary Figure 10. Knockdown of endogenous CRTC2
with CRTC2 shRNA.  Neuro2a cells were transfected with CRTC2 or
scramble shRNA.  After two days, the lysate was immunoblotted for
panTORC to confirm knockdown of CRTC2.  CRTC1 levels were
used as a control to confirm the loading of equal amounts of protein
in each lane.
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Supplementary Figure 11.  S40A CREB expression enhances expression of the
endogenous CREB target genes Arc and Cdk5 in neurons via a CRTC-dependent
mechanism. Cortical neurons were electroporated with WT CREB or S40A CREB and
scramble or CRTC1 siRNA as indicated.  After 3-4 DIV, the mRNA was collected and
quantitative PCR was performed on the indicated genes. RPL3 was used as an internal
control. GAPDH is not a known CREB target gene. Fold-change is plotted relative to
neurons electroporated with WT CREB and scramble siRNA. (n = 4-9, *P < 0.01). Error
bars, means, and s.e.m.
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Supplementary Figure 12. S40A CREB produces approximately a 2.5–3.6-fold increase
in mRNA expression relative to WT CREB.  (a) Cortical neurons were electroporated with
scramble or CREB siRNA.  After 4 DIV, the mRNA was collected, and the mRNA levels of
each gene were measured by quantitative RT-PCR.  (n = 14, *P < 0.05).  (b) Cortical
neurons were electroporated with WT CREB or S40A CREB.  After 3-4 DIV, the mRNA was
collected and quantitative PCR was performed on the indicated genes.  The fold-change was
calculated by subtracting the transcript levels of each gene in neurons transfected with
CREB siRNA (normalized to scramble siRNA mRNA transcription levels) from the transcript
levels of each gene in WT or S40A CREB-expressing neurons (normalized to WT CREB
mRNA transcript levels) and then normalizing these values to WT CREB levels for each
gene. (n = 9, *P < 0.01). Error bars, means, and s.e.m.
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Supplementary Figure 13. Knockdown of endogenous CRTC1
with CRTC1 siRNA.  Cortical neurons were electroporated with
CRTC1 or scramble siRNA.  After 3 DIV, the lysate was
immunoblotted for CRTC1 or CREB. As the electroporation efficiency
was approximately 30%, the ~30% knockdown observed likely
represents significant knockdown in the electroporated cells.
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Supplementary Figure 14.  WT and S40A Flag-tagged CREB are expressed at
similar levels in cortical neurons.  Cortical neurons were electroporated with WT
or S40A CREB.  After 3 DIV, the lysate was immunoblotted for Flag-tagged CREB.
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Supplementary Figure 15.  Expression of S40A CREB enhances axon
outgrowth.  Cortical neurons were electroporated with a GFP construct or a
Flag-tagged WT or S40A CREB construct containing GFP.  Four days later,
the neurons were imaged for GFP. (For each condition, thirty axons were
measured in each of three independent experiments, *P < 0.001). Error bars,
means, and s.e.m.
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Supplementary Figure 16.  Verification of OGT knockout.  Neurons from OGT floxed mice
were electroporated with a GFP construct (control) or with GFP and CRE recombinase
constructs (OGT KO). After 4 DIV, the cells were immunostained with the anti-OGT antibody
DM17.
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OGT
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Supplementary Figure 17.  Verification of OGT overexpression. Neurons from WT
mice were electroporated with a GFP construct (control) or with a Flag-OGT construct
containing GFP.  (a) After 4 DIV, the cells were immunostained for overall O-GlcNAc
levels using the pan-specific O-GlcNAc antibody RL2.  (b) After 4 DIV, OGT
overexpression was verified by Flag M2 affinity gel purification and Western blotting of
the eluent with the anti-OGT antibody DM17.
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Supplementary Figure 18.  Depolarization-induced dendrite growth is blocked
by Wnt2 siRNA, Dkk-1, and Ncad(intra).  Cortical neurons were electroporated with
Flag-tagged WT or S40A CREB constructs containing GFP, along with scramble
siRNA, Wnt2 siRNA, Dkk-1, or Ncad(intra) constructs as indicated. KCl (50 mM) was
added after 3 DIV.  One day later, the neurons were imaged for GFP. Representative
images for each condition are shown from thirty neurons in each of three independent
experiments.  Lengths relative to neurons expressing WT CREB in the absence of
KCl stimulation are shown. (*P < 0.001 relative to scramble siRNA for each respective
genotype). Error bars, means, and s.e.m.
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Supplementary Figure 19.  Expression of S40A CREB enhances dendrite growth, and its
effects can be blocked with Wnt2 siRNA, Dkk-1, Ncad(intra), and CRTC1 siRNA, but not
TrkB-Fc.  (a) Cortical neurons were electroporated with Flag-tagged WT or S40A CREB
constructs containing GFP, along with CRTC1 siRNA, Wnt2 siRNA, Dkk-1, or Ncad(intra)
constructs as indicated.  TrkB-Fc (0.7 µg/ml) or vehicle was added after 1 DIV. Three days
later, the neurons were imaged for GFP.  The longest neurite was assigned as the axon and
the remaining neurites were assigned as dendrites for each group. Staining of representative
cultures with specific axon and dendrite markers confirmed the results. Thirty dendrites were
measured in each of three independent experiments for neurons electroporated with WT or
S40A CREB and scramble siRNA, CRTC1 siRNA, Wnt2 siRNA, Dkk-1, and Ncad(intra) groups.
Twenty dendrites were measured in each of three independent experiments for neurons
electroporated with WT or S40A CREB and treated with TrkB-Fc. Representative images are
shown for each treatment.  (b) Distribution of the total dendrite lengths for the 60 or 90 neurons
described in (a).
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Supplementary Figure 20.  The enhanced axon outgrowth caused by
expression of S40A CREB (Fig. S15) is blocked by TrkB-Fc or CRTC1
knockdown.  Cortical neurons were electroporated with Flag-tagged WT or S40A
CREB constructs containing GFP, along with CRTC1 or scramble siRNA as
indicated. TrkB-Fc (0.7 µg/ml) or vehicle was added after 1 DIV where indicated.
Three days later, the neurons were imaged for GFP. (For each condition, thirty
axons were measured in each of three independent experiments, *P < 0.0001).
Error bars, means, and s.e.m.
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Supplementary Figure 21. Phospho-Ser133 levels are induced in the
amygdala 15 minutes after fear conditioning.  Mice were subjected to auditory
fear conditioning training, and after 15 minutes, the lateral amygdala was removed.
Lysate was chemoenzymatically labeled with a polyethylene glycol mass tag and
immunoblotted for CREB or pSer133 CREB (see Fig. 5a).   Total CREB and
pSer133 CREB levels were measured by combining the signal of both the
unshifted and PEG-shifted bands.  Relative pS133 levels were determined by
normalizing total pSer133 CREB levels to total CREB levels and scaling the control
values to 1. (n = 3, * P < 0.05). Error bars, means, and s.e.m.
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Supplementary Figure 22.  Herpes simplex virus (HSV) infection of the lateral
amygdala of mice. The lateral amygdala [AP = -1.3, ML = +/-3.3, V = -4.8 from bregma]
of 9-10 week old male C57BL/6 mice was injected with WT CREB, S40A CREB, or GFP
HSV (1.5 µl) for 25 min. Three days later, the brains were perfused, fixed, sectioned, and
stained with DAPI.  The sections were imaged for GFP (FITC) and DAPI under a
fluorescence microscope to confirm the injection site.  (a)  Bright field image of a
representative brain section infused with WT CREB vector showing an outline of the
lateral amygdala.  (b)  FITC image of injection site.  (c) DAPI image of (b).
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Supplementary Figure 23.  Inhibition of protein synthesis immediately after
training blocks the memory enhancement of S40A CREB at 2 h.  Replication-
defective HSV vectors expressing WT CREB and GFP, S40A CREB and GFP, or GFP
alone were bilaterally microinjected into the lateral amygdala of mice three days prior to
auditory fear conditioning training.  Mice were injected with anisomycin or saline 5 min
after fear conditioning, and freezing behavior was assessed after 2 h. (n = 6 for WT, n
= 7 for S40A, *P < 0.0005; NS, not significant). Error bars, means, and s.e.m.
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Supplementary Figure 24.  Inhibition of protein synthesis 2 h after training
blocks the memory enhancement of WT CREB at 24 h, but not that of S40A
CREB. Replication-defective HSV vectors expressing WT CREB and GFP, S40A
CREB and GFP, or GFP alone were bilaterally microinjected into the lateral amygdala
of mice three days prior to auditory fear conditioning training.  Mice were injected with
anisomycin or saline 2 h after fear conditioning, and freezing behavior was assessed
after 24 h.  The memory enhancement of S40A CREB at 24 h was anisomycin-
resistant.  (n = 6 for WT, n = 8 for S40A anisomycin, n = 7 for S40A saline, *P < 0.005;
NS, not significant). Error bars, means, and s.e.m.
Nature Chemical Biology: doi:10.1038/nchembio.770
aGalT:
105
75
50
35
?– + + + + +
 Non-glyco
E
m
br
yo
ni
c 
ne
ur
on
s
C
or
te
x
H
ip
po
ca
m
pu
s
C
er
eb
el
lu
m
A
m
yg
da
la
 Mono-glyco
b
 Non-glyco
 Mono-glyco
WT S40A
TT227-8
AA
 -GalT
 cont
TST259-
61AAA
–– + – + – + – +KCl:
A6
–
105
75
50
35
c
0 5 10 30 120 360
 Non-glyco
Mono-glyco
time (min):
 WB: pS133 CREB
WB: Total CREB
105
75
50
35
105
75
50
35
105
75
50
35
–    +
KN-62
–    +
Nimo
–    +
U0126
–    +
CalC 
–    +
CyA
–    +
OA
–    +
Veh
KCl:
d
 Non-glyco
 Mono-glyco
105
75
50
35
e
 Mono-glyco
KCl: – + – +
WT S133A
WB:
Flag-CREB
Non-glyco
50
35
pS133
CREB
WB: CREB WB: Flag-CREB
WB: CREB
WB: Total CREB
Nature Chemical Biology: doi:10.1038/nchembio.770
Non-glyco and pS133
WT A5
WB: CREB
WB: pS133 
CREB
Mono-glyco
Non-glyco
Mono-glyco and pS133
KCl: – + – +
g
105
75
50
35
105
75
50
35
i GalT:
Shock:
– + +
– – +
 Non-glyco
 Mono-glyco
– + +
– – +
WB:Total CREBWB: pS133 CREB
75
50
35
Supplementary Figure 25.  Full Western blots corresponding to Figures 1-5. (a) Figure 1a
Western blot. (b) Figure 1c Western blot. (c) Figure 1d Western blots. (d) Figure 1e
Western blot. (e) Figure 2a Western blot. (f) Figure 2b Western blots. (g) Figure 2c
Western blots. (h) Figure 3b Western blots. (i) Figure 5a Western blot.  See original figure
legends for details.  Vertical lines represent breaks where two non-adjacent lanes of a gel
were aligned.
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Supplementary Figure 26.  Full Western blots corresponding to Supplementary Figures
2-17. (a) Supplementary Figure 2 Western blot. (b) Supplementary Figure 3 Western
blot. (c) Supplementary Figure 4 Western blots. (d) Supplementary Figure 5 Western
blots. (e) Supplementary Figure 9 Western blots. (f) Supplementary Figure 10 Western
blot. (g) Supplementary Figure 13 Western blot. (h) Supplementary Figure 14 Western
blot. (i) Supplementary Figure 17 Western blot.  See original figure legends for details.
Vertical lines represent breaks where two non-adjacent lanes of a gel were aligned.
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Supplementary Table 1.  Primers used for RT-PCR
Gene name Forward primer 5’ – 3’ Reverse primer 5’ – 3’
Arc TGGAGCAGCTTATCCAGAGG TATTCAGGCTGGGTCCTGTC
ATF3 CCAAGAGCCGTTGGGGCAGG TCACTCGGGGGCAGAGTGGG
BDNF IV CAGAGCAGCTGCCTTGATGTT GCCTTGTCCGTGGACGTTTA
Cdk5 TTTCCCTCCCTCCGTG TGGGAAAGGAGCCAATTTATG
CDKN1A GTTCCGCACAGGAGCAAAG GAGTGCAAGACAGCGACAAG
c-fos CCGACTCCTTCTCCAGCAT TCACCGTGGGGATAAAGTTG
GADPH CTGAGTATGTCGTGGAGTCTACTGG GTCATATTTCTCGTGGTTCACACC
NR4A2 GCATACAGGTCCAACCCAGT AATGCAGGAGAAGGCAGAAA
OPA3 GCAAAGGCAAAAGATGGAAC GTGTTCACCGAAGGAAGGAG
PEPCK GGGCCTGCAACCCTGAGCTG GGCGATCCGCAACGCAAAGC
RPL3 TCATTGACACCACCTCCAAA GCACAAAGTGGTCCTGGAAT
UCP1 TTGAGCTGCTCCACAGCGCC CCGCGACTTCGGACTCCTGC
Wnt2 CATAGCCCCCCACCACTGT AGTTCCTTCGCTATGTGATGTTTCT
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Supplementary Table 2.  Primers used for ChIP PCR
Gene name Forward primer 5’ – 3’ Reverse primer 5’ – 3’
Arc GGCTGGCTCTGGGAGGTATTTA CCCCCAGAGCTGAGAGTTCAGA
ATF3 CCAGTTCTCCCTGGAAGCTA CGTTGCATCACCCCTTTTAA
BDNF exon IV TGGACTCCCACCCACTTT GTGGCCGATATGTACTCC
Cdk5 GCTGAAGCTGTCAGGAGGTC GTGCCCCGCTCTTGTTATTA
c-fos CCTCCCTCCTTTACACAG GTCTTGGCATACATCTTTC
PEPCK GGCCTCCCAACATTCATTAAC GTAGCCCGCCCTCCTTGCTTTAA
UCP1 TCCTCTGGGCATAATCAGGAACT CAGGTCTCCAAAGAGCTGCTAGT
Wnt2 CCCGCACACGGAGTCTGACC AATCCATCAGCACCGCGCCC
18S Ribosomal RNA CGCGGTTCTATTTTGTTGGT AGTCGGCATCGTTATGGTC
Nature Chemical Biology: doi:10.1038/nchembio.770
